IMA asks doctors not to prescribe antibiotics for common cold

Image
Press Trust of India New Delhi
Last Updated : Jan 23 2016 | 9:13 PM IST
The Indian Medical Association (IMA) today asked the doctors not to prescribe antibiotics for adults suffering from common cold, bronchitis, sore throat or sinus infections.
These types of infections are the most common reason for visits to the doctor in this period and for outpatient antibiotic prescriptions for adults, it said.
"Over 50 per cent of antibiotic prescriptions may be unnecessary or inappropriate in the outpatient setting," said Dr S S Agarwal, National President of IMA.
Inappropriate use of antibiotics for Acute Respiratory Tract Infections (ARTI) is an important factor contributing to the spread of antibiotic-resistant infections, which is a public health threat, he added.
The IMA has issued a set of guidelines according to which doctors should communicate to their patients suffering from common cold that symptoms can last up to two weeks.
"One should intervene only if the symptoms worsen or exceed the expected time of recovery. Antibiotics should also not be prescribed for uncomplicated bronchitis unless pneumonia is suspected," said IMA Secretary General Dr K K Aggarwal.
In such situations, he said, symptomatic relief using cough suppressants, expectorants, antihistamines, decongestants and beta-agonists are sufficient. Antibiotics should be prescribed for sore throat only if a strep test confirms streptococcal pharyngitis.
"For all other cases, one should recommend analgesic therapy such as aspirin, acetaminophen, nonsteroidal anti-inflammatory drugs, and throat lozenges, which can help reduce pain.
"Uncomplicated sinus infections typically clear up without antibiotics. Antibiotics should be prescribed only if there are persistent symptoms for more than 10 days, or if a patient develops severe symptoms or a high fever, has nasal discharge or facial pain for at least three days in a row, or worsening symptoms following a typical viral illness that lasted five days, which was initially improving," Dr Aggarwal added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 23 2016 | 9:13 PM IST

Next Story